Medtronic plc MDT announced that the FDA has approved a new arm indication for the Guardian Sensor 3 continuous glucose monitor (CGM) used with the MiniMed 670G insulin pump. Notably, the Guardian ...

Medtronic plc. MDT recently made a major development in the field of diabetes management. The company reached an outcome-based agreement with Blue Cross and Blue Shield of Minnesota in relation to the ...

DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of its ...

New No Fingerstick 1 Sensor Integrates with Both the MiniMed 780G System and the Smart InPen System DUBLIN, May 26, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical ...

Medtronic plc MDT recently combined InPen, the smart insulin pen, with its Guardian Connect continuous glucose monitoring system. This follows the company’s acquisition of connected insulin pen ...

DUBLIN - March 12, 2018 - Medtronic plc (MDT), the global leader in medical technology, services and solutions, today announced it received U.S. Food and Drug Administration (FDA) approval for its ...

Medtronic plcMDT announced that the FDA has approved a new arm indication for the Guardian Sensor 3 continuous glucose monitor (CGM) used with the MiniMed 670G insulin pump. Notably, the Guardian ...